In October 2022, the FDA confirmed that we were in the midst of an Adderall shortage, and unfortunately for many people, it's still ongoing.
Adderall — also referred to as amphetamine mixed salts — is a medication used to manage the symptoms of attention deficit hyperactivity disorder (ADHD) and narcolepsy (a chronic sleep disorder). The FDA stated in October that the organization was "in frequent communication with all manufacturers of amphetamine mixed salts, and one of those companies, Teva, is experiencing ongoing intermittent manufacturing delays."
The statement also said that "Other manufacturers continue to produce amphetamine mixed salts, but there is not sufficient supply to continue to meet U.S. market demand through those producers."
Visit the link below to continue reading.